BrainsWay Ltd.

BrainsWay develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and globally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. Founded in 2003, the company is headquartered in Jerusalem, Israel.